SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-18-000087
Filing Date
2018-08-08
Accepted
2018-08-08 16:11:07
Documents
17
Period of Report
2018-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201808088xkdoc.htm 8-K 34575
2 PRESS RELEASE pdli-201808088xkex991.htm EX-99.1 244531
3 PRESENTATION pdli-201808088xkex992.htm EX-99.2 5945
4 INFORMATION SHEET pdli-201808088xkex993.htm EX-99.3 213137
5 pdllogoa05.jpg GRAPHIC 123123
6 slide1a72.jpg GRAPHIC 48372
7 slide2a72.jpg GRAPHIC 216640
8 slide3a72.jpg GRAPHIC 145785
9 slide4a72.jpg GRAPHIC 106141
10 slide5a72.jpg GRAPHIC 122946
11 slide6a72.jpg GRAPHIC 80526
12 slide7a72.jpg GRAPHIC 165339
13 slide8a70.jpg GRAPHIC 101207
14 slide9a69.jpg GRAPHIC 185454
15 slidr69.jpg GRAPHIC 124622
16 slidr70.jpg GRAPHIC 110903
17 slidr71.jpg GRAPHIC 33321
  Complete submission text file 0000882104-18-000087.txt   2654759
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 181001460
SIC: 2836 Biological Products, (No Diagnostic Substances)